Predict your next investment

Nitrome Biosciences company logo
HEALTHCARE | Drug Development
nitromebiosciences.com

See what CB Insights has to offer

Total Raised

$45.9M

Investors Count

6

Nitrome Biosciences Funding, Nitrome Biosciences Valuation & Nitrome Biosciences Revenue

4 Fundings

Nitrome Biosciences's latest funding round was a Series A - II for $7M on November 2, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/2/2021

Series A - II

$7M

1

4/22/2020

Series A

$99M

10

7/1/2019

Convertible Note

$99M

10

1/7/2019

Debt

$99M

10

Date

11/2/2021

4/22/2020

7/1/2019

1/7/2019

Round

Series A - II

Series A

Convertible Note

Debt

Amount

$7M

$99M

$99M

$99M

Investors

Valuation

Revenue

Sources

1

10

10

10

Nitrome Biosciences Investors

6 Investors

Nitrome Biosciences has 6 investors. Bristol-Myers Squibb invested in Nitrome Biosciences's Series A - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/2/2021

11/2/2021

1
Series A - II

Corporation

New York

00/00/0000

00/00/0000

AbbVie Biotech Ventures

Subscribe to see more

Corporate Venture

Illinois

00/00/0000

00/00/0000

Mission Bay Capital

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Sofinnova Partners

Subscribe to see more

Venture Capital

France

00/00/0000

00/00/0000

Dementia Discovery Fund

Subscribe to see more

Venture Capital

United Kingdom

First funding

11/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

AbbVie Biotech Ventures

Mission Bay Capital

Sofinnova Partners

Dementia Discovery Fund

Rounds

1
Series A - II

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Corporate Venture

Venture Capital

Venture Capital

Venture Capital

Location

New York

Illinois

California

France

United Kingdom

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.